Navigation Links
Statement from IDF on studies suggesting possible link between insulin glargine and cancer
Date:6/29/2009

The International Diabetes Federation (IDF) today called for urgent assessment and responses from regulatory authorities into a possible link between the use of insulin glargine (an insulin analogue) and increased risk of cancer based on findings published on 26 June, 2009 in Diabetelogia, the journal of the European Association for the Study of Diabetes (EASD).

The online data published in Diabetelogia is based on four studies relating to a possible link between a long-acting insulin analogue, insulin glargine and cancer. According to EASD, the findings are based on evidence from studies in Germany, Sweden, Scotland and the United Kingdom. The studies however, are not conclusive.

The International Diabetes Federation understands the concern about the Diabetelogia study findings but urges the diabetes community to wait for the current scientific information to be released and calls for urgent further scientific studies to be undertaken in other countries.

The International Diabetes Federation stresses that it is important that people needing insulin do not stop taking the drug. IDF cautioned that people with diabetes should see their doctor for advice before considering any change to their treatment.


'/>"/>
Contact: Kerrita McClaughlyn
media@idf.org
322-543-1639
International Diabetes Federation
Source:Eurekalert

Page: 1

Related medicine news :

1. NJLRA Statement in Response to Roches Discontinuation of Accutane(R)
2. AAHSA Statement on Long-Term Services and Supports CBO Scoring
3. AAHSA Statement on House Ways and Means Committee Hearing
4. Statement of Dr. Elena Rios, MD, MSPH, President and CEO, National Hispanic Medical Association
5. Phyhealth Issues 2008 Audited Financial Statements and Provides Business Update
6. Pelosi Statement on President Obama Signing Smoking Prevention and Tobacco Control Act
7. PhRMA Statement on Medicare Part D Coverage Gap
8. Pelosi Statement on House Committee Chairmens Draft Health Care Reform Proposal
9. Wyeth Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders
10. National Changing Diabetes Program Issues Statement on President Obamas Speech to the American Medical Association
11. Statement of James P. Firman President and CEO, National Council on Aging on World Elder Abuse Awareness Day June 15, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... HealthDay Reporter , , FRIDAY, May 17 (HealthDay News) ... edition of what is considered the "bible" of modern ... continues. "This is unprecedented, the amount of commentary ... of the American Psychiatric Association (APA). "It,s been an ... You have to evaluate it and then make your ...
(Date:5/18/2013)... (May 18, 2013) The use of a ... colonoscopy, according to new research presented today at ... begins days in advance of the procedure, includes ... to be taken at strict intervals. The better ... to see cancer and precancerous polyps in the ...
(Date:5/18/2013)... 2013 Assisted living and retirement ... safety and comfort of their residents. Systems Technologies ... with an effective and cost-efficient solution – VisionLink ... integrated, turnkey communications solution that helps nurses provide ... independence and privacy. , The VisionLink ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 The Communities ... the special places we call home. These are the townships, ... They are the locations where the people are friendly and ... takes viewers off the highways and shares the best in ... both nations with an American sports and film celebrity. It ...
(Date:5/18/2013)... TheBeautyPlace.com answers important questions about the hairloss ... a result of stress, nutrient deficiency or wearing a ... of men suffer from male patterned baldness. ... hair transplant surgery, but additionally carries a hair care ... Bosley Professional Strength. Their product line is a five-step ...
Breaking Medicine News(10 mins):Health News:Latest Edition of Psychiatry's 'Bible' Launched Amid Controversy 2Health News:Latest Edition of Psychiatry's 'Bible' Launched Amid Controversy 3Health News:Latest Edition of Psychiatry's 'Bible' Launched Amid Controversy 4Health News:New smartphone application improves colonoscopy preparation 2Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 2Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 3Health News:Communities of Distinction TV Presents "A Place to Call Home" Segment 2Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 2Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 3
... VanTine HealthDay Reporter , FRIDAY, Dec. 3 (HealthDay News) ... interview, attractive women may be at a disadvantage, a new study ... men were twice as likely to generate requests for an interview, ... up to 30 percent less likely to get a response, whether ...
... FRIDAY, Dec. 3 (HealthDay News) -- If the expression "out ... may be at risk of forgetting about the global AIDS ... coverage of HIV/AIDS fell more than 70 percent in developed ... that tracked coverage in 115 leading broadsheet newspapers in 41 ...
... a quarter of Americans live in rural areas, which consistently ... suburban areas. Among the complex causes for this disparity is ... and almost 4 out of 10 rural residents live ... Finding the time, transportation, and financial resources for travel to ...
... News) -- Young women with a menopause-like condition called ... new study suggests. Women with the condition, called ... hormones, develop hot flashes, typically become infertile and, in ... develop as early as the teens or 20s, according ...
... children born with a rare genetic disease, according to ... Advancement of Science. The research was led by ... at Iowa State University, in collaboration with Dr. Patricia ... the Iowa State College of Veterinary Medicine, the University ...
... Goodwin HealthDay Reporter , THURSDAY, Dec. 2 (HealthDay ... circuitry of brain connections may someday be used to diagnose ... Boston and the University of Utah used MRIs to analyze ... in 30 males aged 8 to 26 with high-functioning autism ...
Cached Medicine News:Health News:Good Looks May Help Land the Interview -- for Men 2Health News:Good Looks May Help Land the Interview -- for Men 3Health News:Dramatic Decline Seen in AIDS News Coverage 2Health News:ALBERT EINSTEIN COLLEGE OF MEDICINE HELPS ADDRESS NEED FOR IMPROVED CANCER CARE IN RURAL AMERICA 2Health News:Depression Screening Urged for Young Women With Menopause-Like Symptoms 2Health News:New discovery prevents symptoms of rare genetic disorder 2Health News:Brain Scan Might Someday Spot Autism 2Health News:Brain Scan Might Someday Spot Autism 3
(Date:5/17/2013)... 17, 2013  PENTAX Medical, a healthcare industry ... global leader in ultrasound imaging, recently announced renewed ... enable further innovation in the development of Endoscopic ... systems and PENTAX Medical endoscopic portfolio have formed ... EUS systems. This agreement will continue to grow ...
(Date:5/17/2013)... May 17, 2013 Oramed Pharmaceuticals ... oral drug delivery systems, announced today that the United ... Company,s Investigational New Drug application(IND) for ORMD-0801, its oral ... have the FDA clearance to proceed," stated ... trial is a major milestone for Oramed and we ...
(Date:5/16/2013)... ZURICH , May 17, 2013 ... Technology and Research (A*STAR) and Switzerland,s ... has been dosed in a Phase 1 clinical trial with ... Qbeta virus-like particle (VLP) technology. In this first Phase 1 ... candidate and its potential to protect against H1N1 influenza infection ...
Breaking Medicine Technology:PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 2PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 3Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6
... Safety and Efficacy of Tengion,s Neo-Bladder Construct ... in Spinal Cord Injury Patients, ... medicine, announced today it has initiated a Phase 2,multi-center clinical trial ... study is being conducted in 10 adult,patients with neurogenic bladder due ...
... risk in ... with osteoporosis, INDIANAPOLIS, Sept. 14 Today, Eli Lilly ... and Drug Administration,(FDA) has approved its osteoporosis drug EVISTA(R) (raloxifene ... breast cancer in two populations:,postmenopausal women with osteoporosis and postmenopausal ...
Cached Medicine Technology:Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ 2Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ 3FDA Approves Lilly's Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women 2FDA Approves Lilly's Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women 3FDA Approves Lilly's Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women 4FDA Approves Lilly's Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women 5FDA Approves Lilly's Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women 6
Spurling-Kerrison (Colclough) Laminectomie Rongeur. 15 cm - 6, thick footplate, large handle, 40 up-cutting, jaws 3 mm wide....
Kerrison (Micro) Laminectomie Rongeur, with ejector. 18 cm - 7 1/8, with thick footplate, small handle, 90 up-cutting, jaws 2 mm wide....
... Instrument Set offers maximum distraction with minimal ... by the Tangent Posterior Impacted Instrument Set ... to reproduce the technique. Set offers 9 ... body distraction. A variety of sizes of ...
Regulates physiological flow within normal ranges of Intraventricular Pressure (IVP) in the supine, sitting or standing position....
Medicine Products: